Fund moves

Becton Dickinson (BDX)Fort Washington Investment Advisors Inc added to its stake +126K shares

Fort Washington Investment Advisors Inc added to its stake in Becton Dickinson, per its Q2 2026 13F.

1.11M
Shares reported · +126K vs prior quarter
0.84%
Disclosed portfolio weight
$168M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 17, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of BDX — reported range $1,001 - $15,000
  2. May 20, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
  3. May 21, 2026CongressDisclosed sale of BDX — reported range $1,001 - $15,000
  4. May 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
  5. Jun 1, 2026InsiderCEO sold ~$405K of BDX shares in the open market
  6. Jun 10, 2026InsiderOfficer sold ~$167K of BDX shares in the open market
  7. Jun 24, 2026InsiderOfficer sold ~$160K of BDX shares in the open market
  8. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep" Foley Tray System Add-A-Foley Catheter REF: A153200 UDI code: 00801741121067¿ 10801741121064 SureStep" Fole…
  9. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bard¿ Foley Tray With Lubri-Sil¿ All-Silicone Foley Catheter REF: 947314 947316 947318 UDI codes: 00801741024924¿ 108…
  10. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: Bardex Lubricath Foley Catheter Tray REF: 899914 899916 899918 UDI codes: 00801741024801¿ 10801741024808 008017410248…
  11. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: (Canada Only) SureStep" Foley Tray System Bardex¿ IC Complete Care¿ REF: A300314AC UDI-DI code: 00801741143243 SureSt…
  12. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: SureStep Intermittent Catheter Tray REF: INTP16 INTS14 INTS14C INTS16 INTS16C PEDINTS06 PEDINTS08 PEDINTS10 UDI code:…
  13. Jun 25, 2026FDARecall: Products that contain the Pericare Wipes: *Bardex¿ I.C. Complete Care¿ Foley Catheter Tray REF: 300316A UDI codes: 00801741024344¿ 10801741024341 *Bardex¿ I.C.…
  14. Jun 26, 2026InsiderOfficer sold ~$11K of BDX shares in the open market
  15. Jul 9, 2026FDARecall: BD ChloraPrep Clear, (2% w/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol), 60 x 1 mL applicators/carton, 0.03fl oz (1 mL) each, STERILE SOLUTIO…
  16. Jul 10, 2026FDAFDA device clearance: Minnesota Four-Lumen Esophagogastric Tamponade Tube - 18 French (0092220); Blakemore Esophageal-Nasogastric Tube - 20 French (0092100); Blakemore Esophageal-Na…

What came next

  1. Jul 19, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On July 19, 2026, Michael D. Garrison, Executive Vice President and President of the Medical Essentials and BioPharma Systems segments of Becton, Dickinson and Company (“BD”), informed BD of his intention to retire.”
  2. Jul 27, 2026InsiderOfficer sold ~$12K of BDX shares in the open market
  3. Jul 30, 2026FDARecall: BD Needle Kit for Powered Driver 15mm x 15Ga, REF: D015151NK, BD Needle Kit for Powered Driver 25mm x 15Ga, REF: D015251NK, BD Needle Kit for Powered Driver 35…
  4. Aug 6, 2026Company filing · Form 8-K · ResultsReported its results
  5. Aug 6, 20265% stakeFirst Eagle Investment Management, LLC reported a passive stake (13G) of 5.1%
  6. Aug 7, 20265% stakeSTATE STREET CORPORATION reported a passive stake (13G) of 5.4%
  7. Aug 10, 2026FDARecall: Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605150; Power-Trialysis Short-Term Straight Dialysis Catheter, REF: 5605200; Power-Trialysis Short…
  8. Aug 10, 2026FDARecall: DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625150; DuoGlide Short-Term Straight Dialysis Catheter, REF: 5625200; DuoGlide Short-Term Straight Dialys…
  9. Aug 11, 2026FDARecall: ForeSight Elite Tissue Oximetry Cable REF HEMFSM10 UDI-DI code: 00690103210927 The non-invasive ForeSight oximeter cable is intended for use as an adjunct moni…
  10. Aug 11, 2026InsiderOfficer sold ~$441K of BDX shares in the open market
  11. Aug 13, 2026InsiderCEO sold ~$768K of BDX shares in the open market
  12. Aug 14, 2026FDAFDA device clearance: EnCor EnCompass™ Breast Biopsy and Tissue Removal System
  13. Aug 26, 2026InsiderOfficer sold ~$31K of BDX shares in the open market
  14. Sep 14, 2026FDAFDA device clearance: BD BBL Mueller Hinton II Broth (Cation-Adjusted); BD Difco Mueller Hinton Broth
  15. Sep 25, 2026FDAFDA device approval: Liverty™ TIPS Stent Graft
  16. Sep 28, 2026InsiderOfficer sold ~$14K of BDX shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Becton Dickinson

For Becton Dickinson, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 28 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BDX page.

How this filing works

Other disclosures at Becton Dickinson

Everything OQRO holds on this company is on its BDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data